| Segment / region | Type | Fiscal year | Currency | Revenue (millions) | Share of revenue |
|---|---|---|---|---|---|
| UNITED STATES | Region | 2025 | USD | 12,790.0 | 58.6% |
| Europe | Region | 2025 | USD | 4,729.0 | 21.7% |
| Asia | Region | 2025 | USD | 3,093.0 | 14.2% |
| Others Country | Region | 2025 | USD | 1,227.0 | 5.6% |
| UNITED STATES | Region | 2024 | USD | 11,663.0 | 57.8% |
| Europe | Region | 2024 | USD | 4,402.0 | 21.8% |
| Asia | Region | 2024 | USD | 2,906.0 | 14.4% |
| Others Country | Region | 2024 | USD | 1,207.0 | 6.0% |
| UNITED STATES | Region | 2023 | USD | 11,113.0 | 57.4% |
| Europe | Region | 2023 | USD | 4,244.0 | 21.9% |
| Asia | Region | 2023 | USD | 2,913.0 | 15.0% |
| Others Country | Region | 2023 | USD | 1,102.0 | 5.7% |
| UNITED STATES | Region | 2022 | USD | 10,722.0 | 56.8% |
| Europe | Region | 2022 | USD | 4,043.0 | 21.4% |
| Asia | Region | 2022 | USD | 3,047.0 | 16.2% |
| Others Country | Region | 2022 | USD | 1,058.0 | 5.6% |
| UNITED STATES | Region | 2021 | USD | 10,969.0 | 54.2% |
| Europe | Region | 2021 | USD | 4,751.0 | 23.5% |
| Asia | Region | 2021 | USD | 3,272.0 | 16.2% |
| Others Country | Region | 2021 | USD | 1,255.0 | 6.2% |
| UNITED STATES | Region | 2020 | USD | 9,716.0 | 56.8% |
| Europe | Region | 2020 | USD | 3,480.0 | 20.3% |
| Asia | Region | 2020 | USD | 2,568.0 | 15.0% |
| Others Country | Region | 2020 | USD | 1,353.0 | 7.9% |
| Medical | Product | 2025 | USD | 11,456.0 | 52.5% |
| Interventional | Product | 2025 | USD | 5,217.0 | 23.9% |
| Life Sciences | Product | 2025 | USD | 5,167.0 | 23.7% |
| Medical | Product | 2024 | USD | 10,074.0 | 49.8% |
| Life Sciences | Product | 2024 | USD | 5,191.0 | 25.6% |
| Interventional | Product | 2024 | USD | 4,980.0 | 24.6% |
| Medical | Product | 2023 | USD | 9,502.0 | 49.1% |
| Life Sciences | Product | 2023 | USD | 5,133.0 | 26.5% |
| Interventional | Product | 2023 | USD | 4,736.0 | 24.5% |
| Medical | Product | 2022 | USD | 8,841.0 | 46.9% |
| Life Sciences | Product | 2022 | USD | 5,564.0 | 29.5% |
| Interventional | Product | 2022 | USD | 4,464.0 | 23.7% |
| Medical | Product | 2021 | USD | 9,479.0 | 46.8% |
| Life Sciences | Product | 2021 | USD | 6,530.0 | 32.3% |
| Interventional | Product | 2021 | USD | 4,239.0 | 20.9% |
| Medical | Product | 2020 | USD | 8,680.0 | 50.7% |
| Life Sciences | Product | 2020 | USD | 4,675.0 | 27.3% |
| Interventional | Product | 2020 | USD | 3,762.0 | 22.0% |
Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.
